Please ensure Javascript is enabled for purposes of website accessibility

Should You Get A Vaccine If You've Already Recovered From COVID?

By Morgan McSweeney - Jan 21, 2021 at 10:19AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A doctor explains why it's smart to still get the COVID vaccine after getting infected.

The U.S. has been rolling out COVID vaccines to its population for just over a month now. As of today, 16.5 million doses have been administered -- 9 million from Pfizer (PFE -1.83%) and its partner BioNTech (BNTX -1.72%) and 7 million from Moderna (MRNA -3.21%). Both mRNA vaccines have demonstrated exceptionally high efficacy and are hugely important tools in combatting the coronavirus pandemic. 

Considering more than 24 million cases of COVID-19 have been reported in the U.S. since the start of the pandemic, it's natural to ask: "If I already had COVID, do I still need a vaccine?" You do, and here's why:

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$137.71 (-3.21%) $-4.57
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$50.40 (-1.83%) $0.94
BioNTech SE Stock Quote
BioNTech SE
BNTX
$157.06 (-1.72%) $-2.74

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.